Artificial Gastric Fluid Acid Resistance Testing: Principles, Methods, and Applications

Artificial gastric fluid acid resistance testing is a laboratory method that evaluates how probiotics, enteric-coated products, functional foods, and polymeric materials survive the highly acidic environment of the human stomach. By exposing samples to simulated gastric fluid (pH 1.2 hydrochloric acid with pepsin) at 37°C, laboratories can quantify microbial survival rates, disintegration behavior, and material stability before products reach consumers. This article explains the test principles, preparation of artificial gastric fluid, applicable standards, sample types, testing items, procedures, and typical applications.

Technical Overview

Artificial gastric fluid, also known as simulated gastric fluid (SGF), is a chemically defined medium that reproduces the acidic and enzymatic conditions of the fasting human stomach. Under standard pharmacopoeial formulations, it consists of dilute hydrochloric acid adjusted to pH 1.2, often combined with pepsin and sodium chloride to approximate native gastric secretions. Because gastric acid is one of the most aggressive biological barriers that an ingested product must pass through, acid resistance testing has become a core evaluation step for probiotics, delayed-release dosage forms, encapsulated ingredients, and specialty materials.

During a typical test, samples are immersed in freshly prepared artificial gastric fluid and incubated at 37 ± 1°C with gentle agitation for a defined exposure period, usually 2 to 3 hours to reflect average gastric residence time. Depending on the sample type, endpoints may include viable cell counts, disintegration time, mass loss, dimensional change, coating integrity, or retention of mechanical properties. Results are used to support formulation development, quality control, regulatory dossiers, and product claims related to gastrointestinal survival.

Relevant standards and reference frameworks include:

• United States Pharmacopeia (USP) general chapters covering dissolution media and simulated gastric fluid formulations
• Chinese Pharmacopoeia (ChP) general chapters on the preparation of artificial gastric and artificial intestinal fluids
• European Pharmacopoeia (Ph. Eur.) and Japanese Pharmacopoeia (JP) disintegration and dissolution requirements
• GB 4789.35 and related national food microbiology standards for the enumeration of lactic acid bacteria
• Industry guidance from the International Scientific Association for Probiotics and Prebiotics (ISAPP) on strain characterization

Testing Samples

Probiotics and Microbial Preparations

Lactic acid bacteria such as Lactobacillus, Bifidobacterium, Lactococcus, and Streptococcus thermophilus, as well as Bacillus spores and yeasts, are the most frequently tested sample category. Because live microorganisms must transit the stomach before exerting their effects in the intestine, their survival in artificial gastric fluid is a key functional indicator. Both single strains and finished products, including capsules, sachets, tablets, drops, and fermented foods, can be evaluated.

Enteric-Coated and Delayed-Release Dosage Forms

Enteric-coated tablets, pellets, capsules, and softgels are designed to remain intact in the stomach and release their contents in the intestine. Acid resistance testing verifies that coatings resist disintegration, cracking, and premature release during the acidic stage, typically requiring no visible damage after 120 minutes in pH 1.2 medium.

Functional Foods and Dietary Supplements

Microencapsulated omega-3 oils, enzyme preparations, vitamins, plant extracts, and other bioactive ingredients are tested to confirm that protective matrices shield sensitive compounds from gastric acid. The test helps developers compare encapsulation technologies such as spray drying, fluid bed coating, and liposomal encapsulation.

Polymer Materials and Ingestible Devices

Capsule shells, gastric-retentive dosage form materials, orally ingestible sensors, film coatings, and component materials that may contact gastric juice are assessed for mass loss, swelling, and retention of mechanical strength after acid exposure.

Testing Items

Common evaluation parameters include:

• Acid survival rate of microorganisms expressed as log CFU reduction or percentage survival
• Disintegration time and behavior of coated or compressed forms in acidic medium
• Mass loss, swelling ratio, and dimensional stability of materials
• Tensile strength, elongation at break, and hardness retention
• Coating integrity, surface cracking, blistering, or delamination observed visually or microscopically
• Release or leakage of encapsulated active ingredients into the acid phase
• Morphological and structural changes examined by optical microscopy or scanning electron microscopy
• Changes in pH, conductivity, or appearance of the test medium during exposure

Testing Methods

Preparation of Artificial Gastric Fluid

A standard pharmacopoeial preparation uses dilute hydrochloric acid adjusted to pH 1.2, combined with pepsin at approximately 10 g per liter and, in some formulations, 2.0 g of sodium chloride per liter, brought to final volume with purified water. The fluid is freshly prepared, sterilized or filtered when microbial testing requires it, and pre-warmed to 37°C before use. An enzyme-free version containing only dilute hydrochloric acid may be used when the study focuses purely on physicochemical acid resistance, and custom pH levels such as pH 3.0 can simulate fed or hypochlorhydric stomach conditions.

Test Procedure

• Sample preparation: homogenize powders or finished products, cut materials into defined dimensions, and record initial mass, size, or viable counts
• Immersion or inoculation: introduce the sample into artificial gastric fluid at a defined ratio, for example 1 g of product per 100 mL of medium, or a microbial inoculum of approximately 10⁸ to 10⁹ CFU/mL
• Incubation: maintain the system at 37 ± 1°C with shaking or stirring at approximately 100 rpm for the scheduled duration
• Sampling: withdraw aliquots at defined intervals, commonly 0, 30, 60, 120, and 180 minutes
• Quenching: immediately neutralize or dilute aliquots with phosphate buffer or sodium bicarbonate solution to halt acid and enzyme activity

Analysis and Calculation

For microbial samples, serial dilutions are plated on appropriate media such as MRS agar, with anaerobic incubation where required, and viable counts are determined. Survival rate is calculated as the count at each time point divided by the initial count, multiplied by 100. For materials and dosage forms, post-exposure samples are rinsed, dried to constant weight, and re-measured for mass, dimensions, and mechanical properties. Many studies continue with transfer into artificial intestinal fluid at approximately pH 6.8, containing bile salts and pancreatin, to simulate complete gastrointestinal transit. A comprehensive report includes raw data, survival or degradation curves, photographic and microscopic evidence, and conclusions against predefined acceptance criteria.

Applications

Artificial gastric fluid acid resistance testing supports a wide range of development and regulatory activities:

• Screening and selection of probiotic strains with high gastrointestinal survival for new product development
• Verification of encapsulation and enteric coating technologies during formulation optimization
• Quality control and batch release testing for delayed-release supplements and pharmaceuticals
• Technical dossier support for health food registration, label claims, and scientific substantiation
• Material selection and safety assessment for orally administered devices and ingestible components
• Academic research on microbial gastrointestinal transit and digestion behavior of functional ingredients

FAQ

Question: What is artificial gastric fluid made of?

Answer: Standard formulations contain dilute hydrochloric acid adjusted to approximately pH 1.2, pepsin at about 10 g per liter, and in some pharmacopoeias 2.0 g of sodium chloride per liter, all diluted with purified water to the final volume.

Question: Why is the test performed at pH 1.2 and 37°C?

Answer: pH 1.2 represents the acidity of a fasting human stomach, while 37°C reproduces core body temperature, together creating a worst-case yet physiologically relevant gastric environment.

Question: How long should samples be exposed to the acid?

Answer: An exposure of 2 to 3 hours reflects typical gastric residence time. Extended protocols up to 4 hours or shortened kinetic profiles with 30-minute intervals can be designed according to the product type and study objective.

Question: Should pepsin be included in the fluid?

Answer: Pepsin is included when simulating the enzymatic digestive environment, which is standard for probiotic and dissolution studies. An enzyme-free acid solution is acceptable for purely physicochemical material resistance testing.

Question: What is a typical acceptance criterion for probiotics?

Answer: Criteria vary by product and market, but developers commonly target a survival rate of at least 50 percent after 2 to 3 hours of acid exposure, or a viable count that remains above the labeled minimum, for example 1 million CFU per gram, at the end of shelf life.

Question: Can the test be combined with intestinal fluid testing?

Answer: Yes. Sequential exposure to artificial gastric fluid followed by artificial intestinal fluid containing bile salts and pancreatin at approximately pH 6.8 provides a full in vitro digestion model and is recommended for comprehensive gastrointestinal survival assessment.